4 studies found for:    17117182 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
Conditions: Papillomavirus Infections;   Genital Diseases, Female
Interventions: Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80;   Biological: Placebo (mcg) (Aluminum Adjuvant)225;   Biological: Placebo (mcg) (Aluminum Adjuvant) 450
2 Recruiting Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.
Conditions: Transplantation;   Systemic Lupus Erythematosus;   Systemic Immune Disease
Intervention: Biological: HPV prophylactic vaccine Gardasil
3 Unknown  Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?
Conditions: Cervical Cancer;   Hpv;   Warts
Intervention: Biological: Quadrivalent HPV for types 6, 11, 16 and 18
4 Completed
Has Results
Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers
Condition: Human Papillomavirus Infection
Intervention: Biological: Gardasil

Indicates status has not been verified in more than two years